OTAC Q & A webinar: changes to the opioid treatment program

Following a recent announcement by the Federal Government, major changes to the funding of medications under the opioid treatment program (which include methadone and buprenorphine pharmacotherapies for the treatment of opioid use disorder) will commence on 1 July 2023.

In this special webinar Q & A session by OTAC (Opioid Treatment Accreditation Course) on Tuesday 20 June 6 – 7 pm, experts will provide an update on this announcement and what it may mean for health professionals who provide opioid treatment pharmacotherapies in various settings within New South Wales.

Register now